Correlation of peritumoral edema and microvessel density with tissue expression of VEGF, semaphorins 3A and 3C in patients with meningioma

Mahboobeh Razmkhah

Abstract


Background: Several angiogenic factors correlate with angiogenesis in meningioma while their exact role is yet to be identified. Semaphorins are described with a variety of physiological functions including angiogenesis and migration of neural crest cells. Objective. We aimed to determine the correlation of semaphorin 3A, 3C (Sema 3A and 3C) and vascular endothelial growth factor (VEGF) expression with microvessel density (MVD) and peritumoral brain edema (PTBE) in meningioma. Methods. In this study 21 patients with grade I meningioma were included. PTBE was measured on axial and coronal brain MRI. Tissue expression of semaphorin 3A, 3C and VEGF were determined using quantitative real-time PCR (qRT-PCR). Result. We found that tumor edema index was negatively associated with tissue expression of semaphorin 3C (r= 0.437, p=0.048). Sema 3A and VEGF did not show statistically significant correlation with tumor characteristics studied (p> 0.05). We also found that the mean vascular density of the menigiomas was positively associated with intra operative blood loss (r=0.503, p=0.010). Conclusion: Our data indicates an inverse correlation of Sema3C and peritumoral edema, while no correlations could be shown for Sema 3A and VEGF. Thus Sema3C may be identified as an appropriate inhibitor of pathological angiogenesis in human meningioma. However, confirmation of this finding in a larger dataset is warranted.


Full Text:

PDF (FULL TEXT)

References


Rockhill J, Mrugala M, Chamberlain MC. Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurg Focus 2007;23:E1.

Backer-Grøndahl T, Moen BH, Torp SH. The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol 2012;5:231-242.

Barresi V. Angiogenesis in meningiomas. Brain Tumor Pathol 2011;28:99-106.

Kandemir NO, Narli ZI, Kalayci M, Ozdamar SO. A Rare Pattern of Angiogenesis in Meningiomas: Glomeruloid Microvascular Proliferation. Turk Neurosurg 2014;24:765-769.

Nagane M. [Anti-angiogenic therapy for malignant glioma]. Gan to Kagaku Ryoho 2014;41:141-147.

Dharmalingam P, Kumar VR, Verma SK. Vascular endothelial growth factor expression and angiogenesis in various grades and subtypes of meningioma. Indian J Pathol Microbiol 2013;56:349.

Hou J, Kshettry VR, Selman WR, Bambakidis NC. Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor–directed therapy. Neurosurg Focus 2013;35:E2.

Nassehi D. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Dan Med J 2013;60:B4626.

Barresi V, Tuccari G.Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas. Neuropathol 2010;30:537-546.

Barresi V, Tuccari G. Evaluation of neo-angiogenesis in a case of chordoid meningioma. J Neurooncol 2009;95:445-447.

Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, et al. The role of the semaphorins in cancer. Cell Adh Migr 2016;10:652-674.

Vaitkienė P, Skiriutė D, Steponaitis G, Skauminas K, Tamašauskas A, et al. High level of Sema3C is associated with glioma malignancy. Diagn Pathol 2015;10:1.

Siegel R, Naishadham D, Jemal A.Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.

Lee K-J, Joo W-I, Rha H-K, Park H-K, Chough J-K, et al. Peritumoral brain edema in meningiomas: correlations between magnetic resonance imaging, angiography, and pathology. Surg Neurol 2008;69:350-355.

Otsuka S, Tamiya T, Ono Y, Michiue H, Kurozumi K, et al. The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol 2004;70:349-357.

Nam DH, Lee SK, Whang SH, Shin HJ, Lee JI, et al. A study of the effects of clinicobiological factors upon the meningioma-associated peritumoral edema formation. J Korean Neurosurg Soc 1998;27:453-459.

Luo Y, Raible D, Raper JA. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 1993;75:217-227.

Acevedo LM, Barillas S, Weis SM, Göthert JR, Cheresh DA. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 2008;111:2674-2680.

Kim B-W, Kim M-S, Kim S-W, Chang C-H, Kim O-L. Peritumoral brain edema in meningiomas: correlation of radiologic and pathologic features. J Korean Neurosurg Soc 2011;49:26-30.

Barresi V, Vitarelli E, Cerasoli S. Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density. Virchows Arch 2009;454:563-571.

Gu C, Giraudo E.The role of semaphorins and their receptors in vascular development and cancer. Exp Cell Res 2013;319:1306 – 1316.

Rieger J, Wick W, Weller M. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 2003;42: 379 – 389

Miyato H, Tsuno NH, Kitayama J. Semaphorin 3C is involved in the progression of gastric cancer. Cancer Sci 2012;103: 1961 – 1966

Banu N, Teichman J, Dunlap-Brown M, Villegas G, Tufro A. Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J 2006;20:2150-2152.

Yang WJ, Hu J, Uemura A, Tetzlaff F, Augustin HG, et al. Semaphorin‐3C signals through Neuropilin‐1 and PlexinD1 receptors to inhibit pathological angiogenesis. EMBO Mol Med 2015;7:1267-1284.

Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, et al. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci USA 2002; 99: 383 – 388.

Maione F, Molla F, Meda C, Latini R, Zentilin L, et al. Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J clin Invest 2009;119:3356-3372.

Neufeld G, Sabag AD, Rabinovicz N, Kessler O. Semaphorins in angiogenesis and tumor progression. Cold Spring Harb Perspect Med 2012;2:a006718.

Li K, Chen M, Li L, Lu M, Shao C, et al. The predictive value of semaphorins 3 expression in biopsies for biochemical recurrence of patients with low-and intermediate-risk prostate cancer. Neoplasma 2012;60:683-689.




DOI (PDF (FULL TEXT)): http://dx.doi.org/10.31557/APJCB.2018.3.4.93

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Asian Pacific Journal of Cancer Biology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


 

  

PORTICO

 

Asia Pacific Organization for Cancer Prevention 

West Asia Organization for Cancer Prevention